AI Summary
This article discusses how non-coding DNA variants play a role in childhood cancer, specifically acute lymphoblastic leukemia (ALL), developing resistance to chemotherapy. This highlights the importance of understanding how non-coding DNA impacts cancer treatment outcomes.
Non-coding DNA variants contribute to acute lymphoblastic leukemia (ALL) chemotherapy resistance.